Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Brokerages
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has earned an average recommendation of “Buy” from the ten brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and three have given a strong buy rating to the company. […]
